Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Recro Pharma Inc (NASDAQ:REPH)

8.71
Delayed Data
As of Oct 17
 +0.06 / +0.69%
Today’s Change
5.81
Today|||52-Week Range
10.17
+8.06%
Year-to-Date
No recent news for Recro Pharma Inc.

Today’s Trading

Previous close8.65
Today’s open8.67
Day’s range8.65 - 8.75
Volume94,098
Average volume (3 months)112,698
Market cap$164.9M
Dividend yield--
Data as of 3:59pm ET, 10/17/2017

Growth & Valuation

Earnings growth (last year)-1,442.86%
Earnings growth (this year)+17.29%
Earnings growth (next 5 years)--
Revenue growth (last year)+33.46%
P/E ratioNM
Price/Sales1.25
Price/Book2.30

Competitors

 Today’s
change
Today’s
% change
TRVNTrevena Inc-0.29-13.62%
RDHLRedhill Biopharma Lt...-0.16-1.78%
PPHMPeregrine Pharmaceut...-0.07-1.77%
ACRXAcelRx Pharmaceutica...-0.20-10.26%
Data as of 3:59pm ET, 10/17/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)-$0.73
Annual revenue (last year)$69.3M
Annual profit (last year)-$30.2M
Net profit margin-43.56%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Gerri Henwood
Chief Financial Officer
Michael Celano
Corporate headquarters
Malvern, Pennsylvania

Forecasts